Cosmetics Weekly Trademark Review: Sept. 18 - Sept. 25
This article was originally published in The Rose Sheet
Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
You may also be interested in...
The German biotech has raised a significant sum to advance its T-cell therapies for solid tumors developed using its transgenic mouse technology platform.
Avalon Healthcare appoints two new directors; Lantheus Holdings appoints new chief accounting officer; and more.
It may not yet be approved for marketing, but UCB’s potential blockbuster psoriasis drug has already got the all-clear from NICE, the health technology body that appraises new products for use in England and Wales.